Abliva AB (publ) (ABLI.ST)

SEK 0.42

(-0.83%)

Long Term Debt Summary of Abliva AB (publ)

  • Abliva AB (publ)'s latest annual long term debt in 2023 was 424 Thousand SEK , down -20.6% from previous year.
  • Abliva AB (publ)'s latest quarterly long term debt in 2024 Q2 was 216 Thousand SEK , down 0.0% from previous quarter.
  • Abliva AB (publ) reported annual long term debt of 534 Thousand SEK in 2022, down 0.0% from previous year.
  • Abliva AB (publ) reported annual long term debt of - SEK in 2021, down -100.0% from previous year.
  • Abliva AB (publ) reported quarterly long term debt of 216 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.
  • Abliva AB (publ) reported quarterly long term debt of 424 Thousand SEK for 2023 FY, down -20.6% from previous quarter.

Annual Long Term Debt Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Long Term Debt of Abliva AB (publ) (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 424 Thousand SEK -20.6%
2022 534 Thousand SEK 0.0%
2021 - SEK -100.0%
2020 92 Thousand SEK -74.52%
2019 361 Thousand SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%

Peer Long Term Debt Comparison of Abliva AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 94.359%
Ziccum AB (publ) 286 Thousand SEK -48.252%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 80.297%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 50.118%
Genovis AB (publ.) 74.8 Million SEK 99.433%
Intervacc AB (publ) 142 Thousand SEK -198.592%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 85.867%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 98.699%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 99.35%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 90.13%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.59%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 57.6%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.955%
Camurus AB (publ) 13.61 Million SEK 96.885%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 98.27%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.95%
Cyxone AB (publ) 74 Thousand SEK -472.973%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 70.474%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 98.673%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -211.765%
SynAct Pharma AB 58 Thousand SEK -631.034%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 50.118%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 75.923%
BioInvent International AB (publ) 14.53 Million SEK 97.083%
Alzinova AB (publ) 800 Thousand SEK 47.0%
Oncopeptides AB (publ) 106.48 Million SEK 99.602%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.533%
Diamyd Medical AB (publ) 30.67 Million SEK 98.618%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.624%
Ascelia Pharma AB (publ) 176 Thousand SEK -140.909%
Diagonal Bio AB (publ) - SEK -Infinity%